In particular, in the exosomal DNA derived from human melanoma (BRAF positive) and NSCLC (EGFR positive) cell lines, Thakur and colleagues were able to detect the very same driver mutations of the parental cell line [85]. This evidence concerns the gene BRAF and non-small cell lung carcinoma.